The common position on the sixth framework programme was agreed at Council in December 2001 and formally adopted on 27 June 2002, following a co-decision procedure with the European Parliament. That decision established the overall funding for the programme at over €16 billion and the allocations for the specific themes within the programme. This included an allocation of €2.255 billion for the theme relating to life sciences, genomics and biotechnology for health. The latter includes stem cell research involving adult and embryonic cells.